A little more about us
The Canadian Partnership Against Cancer is an independent organization funded by the federal government to accelerate action on cancer control for all Canadians. The Partnership works with cancer experts, charitable organizations, governments, cancer agencies, national health organizations, patients, survivors and others to implement Canada’s cancer control strategy.
The Partnership’s work spans the cancer control continuum, from prevention and screening to research and supportive care. Our collaborative approach is mindful of the patient voice, and strives to be culturally responsive to the needs of First Nations, Inuit and Métis communities.
The Partnership evolved from the Canadian Strategy for Cancer Control – a volunteer-driven coalition of cancer experts, patients and survivors that drafted Canada’s first national cancer control plan and advocated successfully for its funding.
The coalition’s vision for a coordinated, pan-Canadian strategy led the federal government to announce the creation of the Canadian Partnership Against Cancer, which began operations in April 2007 with $250 million in government funding. The federal government created the Partnership with an initial five-year mandate to implement this national cancer control strategy, as well as to assess whether this model was an effective model in improving cancer control in Canada.
The Partnership’s second five-year mandate began April 1, 2012 and focuses on the cancer control community’s shared priorities for 2012-17 as documented in the organization’s strategic plan, Sustaining Action Toward a Shared Vision. This strategic plan is the evolution of Canada’s national cancer strategy. It builds on progress already made in cancer control and reflects emerging needs and priorities. The Partnership’s organization structure supports the execution of this plan in collaboration with its partners.
The Partnership’s Board of Directors reflects the broad range of stakeholders in the cancer control domain. The board is made up of representatives from cancer and health organizations; federal, provincial and territorial government agencies and departments; patient organizations; individuals and families affected by cancer; clinicians and health-care providers; researchers and the Aboriginal community.
Members of the board:
Chris PowerChair, Canadian Partnership Against Cancer
Chris Power joined the Partnership’s Board of Directors in 2009 and was elected Chair in 2014.
Ms. Power is Chief Executive Officer of the Canadian Patient Safety Institute. Previously, she was President and CEO of Capital District Health Authority in Halifax for nine years, where she provided strategic leadership to an organization that served the health needs of the residents of Halifax Regional Municipality and West Hants, and patients throughout the Maritimes. She also holds appointments on several boards at national and regional levels.
Ms. Power holds a Bachelor of Science degree in Nursing from Mount Saint Vincent University and a Master’s degree in Health Services Administration from Dalhousie University. She is a certified health executive with the Canadian College of Health Service Executives, and holds a Fellowship in Management for executive nurses from the Wharton School, University of Pennsylvania.
In 2003, Ms. Power received the Award for Excellence and Innovation from the Canadian College of Health Leaders and in 2007, she received an Award of Excellence from the Halifax Progress Club. In 2007, 2008 and 2009 she was named one of Canada’s Top 100 Most Powerful Women in the public sector and in 2010 was inducted into the Hall of Fame of Canada’s Top 100 Most Powerful Women. Ms. Power has been named one of the top 50 CEOs in Atlantic Canada for five years and in 2013 was inducted into the Hall of Fame. In 2010, she received the Consumers Choice Award for Business Woman of the Year in Nova Scotia and in 2012 and 2013 was named one of Canada’s Top 25 Women of Influence. In 2013, she received an Honorary Doctorate of Civil Law from Saint Mary’s University.
Ms. Power’s love of family, strong faith and gift of singing keep her grounded in what’s important.
Graham Sher, MDVice Chair, Canadian Partnership Against Cancer
Dr. Graham Sher joined the Canadian Partnership Against Cancer’s Board of Directors in June 2012 and serves as Vice-Chair of the Board.
Dr. Sher is the Chief Executive Officer of Canadian Blood Services, the agency charged with managing Canada’s national blood, plasma and stem cell programs in all provinces and territories across Canada, excluding Quebec, as well as coordinating inter-provincial services for organ and tissue donation and transplantation across the country.
Dr. Sher sits on a number of blood system and health-care related advisory bodies, and has provided consulting support to other countries in the transformation of their blood systems. Dr. Sher is a founding member of the Alliance of Blood Operators and is the first international director, and current President of AABB (formerly the American Association of Blood Banks).
Tracey Barbrick joined the Canadian Partnership Against Cancer’s Board of Directors in 2015.
Ms. Barbrick assumed the role of Associate Deputy Minister of Health and Wellness for Nova Scotia in January, 2015. She joined the Nova Scotia Department of Health and Wellness as Director, Policy and Planning in January 2011, and became the Chief of Policy and Intergovernmental Affairs in 2013 – a position she held until her appointment as Associate Deputy Minster. Ms. Barbrick has worked for the Nova Scotia provincial government since 2001, where she has also worked for the departments of Health Promotion and Protection, Environment and Labour.
Ms. Barbrick has provided leadership in the areas of legislative policy, organizational design, and strategic planning. Most recently, Ms. Barbrick was an instrumental part in consolidating Nova Scotia’s health delivery system ensuring strong governance design, clear roles and accountabilities, with a focus on high quality health services and performance. As part of that consolidation, Ms. Barbrick is leading the redesign of the provincial government organizational design to support its role in that health care system.
Ms. Barbrick holds a Bachelor in Science degree from St. Francis Xavier University and a Masters in Public Administration from Dalhousie. She has had a diverse career beginning in the private sector in both chemical manufacturing and the aerospace industry, followed by positions with both municipal and provincial governments.
Ms. Barbrick believes that working together, communities, health care professionals and government can create a sustainable health care system that focuses not just on caring for Nova Scotians when they are sick, but helping them stay well.
Ewan Clark joined the Partnership’s Board of Directors in 2013 and serves as Vice-Chair of the Governance and Nominating Committee.
Mr. Clark carries on a private legal practice with Cox & Palmer on Prince Edward Island and is an active member of the Law Society of Prince Edward Island and the Canadian Bar Association. He is also actively engaged as a coach, volunteer, and in other roles with schools, sports teams and other initiatives in his community.
Mr. Clark received a Bachelor of Arts degree from the University of Prince Edward Island and a Bachelor of Laws degree from the University of New Brunswick. He was called to the Bar and has practiced both in New Brunswick and on Prince Edward Island.
Mr. Clark has a longstanding personal commitment to fighting cancer arising from family members experiencing the disease. He has volunteered with the Canadian Cancer Society for many years, having held numerous advocacy and leadership roles in New Brunswick and Prince Edward Island and serving as Chair of the Canadian Prostate Cancer Research Initiative. Mr. Clark also served on the Canadian Cancer Society’s National Board of Directors and was named an Honorary Life Member.
Darren Dick joined the Partnership’s Board of Directors in 2012 and serves as Chair of the Governance and Nominating Committee.
Mr. Dick is the Development Officer for the Faculty of Management and Rowe School of Business at Dalhousie University and is also the President of DLD Management Ltd. Prior to this, he spent 20 years as a Senior Financial Advisor with Assante Wealth Management Limited. He also serves as a member of the Canadian Cancer Society’s National Finance, Audit and Risk Management Committee.
Mr. Dick is a Commerce graduate from New Brunswick’s Mount Allison University.
Mr. Dick first became involved in cancer control shortly after his own diagnosis with malignant melanoma in 1988 at the age of 21. His volunteer commitment has primarily been with the Canadian Cancer Society where he has been awarded an Honorary Life Membership. He has served as Chair of the Nova Scotia Division Board of Directors, as a Director at Large on the National Board and as the Director of Major Gifts for the Society’s Daffodil Place Capital Campaign in Nova Scotia. In 2012, Mr. Dick completed a two-year term on the Board of the Canadian Cancer Research Alliance.
Mr. Dick is called upon frequently to speak about his cancer experience and delivers a message of hope and call to action for all Canadians touched by cancer.
Pamela Fralick joined the Partnership’s Board of Directors in 2013.
Ms. Fralick is President and CEO of the Canadian Cancer Society. Her past roles include President and CEO of the Canadian Healthcare Association, CEO of the Canadian Physiotherapy Association, CEO of the Collegium of Work and Learning and executive positions with the Canadian Centre on Substance Abuse and Health Canada’s Alcohol and Other Drugs Unit. Ms. Fralick has also served as chair of the Health Action Lobby (HEAL) and co-chair of the Canadian Coalition for Public Health in the 21st Century (CCPH21).
Ms. Fralick holds a Bachelor of Arts in French and Psychology and a Master of Arts in research psychology from Carleton University, as well as a Master of Public Administration from Queen’s University.
Ms. Fralick has been active in many organizations as a senior volunteer, including the Centre for Addiction and Mental Health, the University of Ottawa Institute of Mental Health Research, Triathlon Canada and the International Triathlon Union. Currently, she sits on the Boards of the Canada Dance Festival and Outward Bound Canada.
Karen Herd joined the Canadian Partnership Against Cancer’s Board of Directors in 2013.
Ms. Herd assumed the role of Deputy Minister of Health for Manitoba in July, 2013. She joined Manitoba Health as Executive Director, Finance in 2005 and became the Assistant Deputy Minister and Chief Financial Officer in 2008. In April 2012, Ms. Herd was appointed the Associate Deputy Minister and Chief Financial Officer for Manitoba Health—a position she held until her appointment as Deputy Minister. Ms. Herd has worked in the provincial health sector since 1998.
Ms. Herd holds a Bachelor of Commerce from the University of Manitoba and has been a Chartered Accountant for more than 20 years.
Ms. Herd is also a member of the Institute of Corporate Directors, recently completing the Not-For-Profit governance course. She has taught Finance for Non-Financial Managers in the Management Development for Women Program at the University of Manitoba and the Health Services Finance course at Red River College.
Eshwar Kumar, MBBS
Dr. Eshwar Kumar joined the Partnership’s Board of Directors in 2013.
Dr. Kumar is the Co-CEO of the New Brunswick Cancer Network Department of Health, a position he has held since 2005. He has been practicing as a Radiation Oncologist in Saint John, New Brunswick since 1984 with a special interest in the management of breast cancer, lymphomas, GU cancer and thyroid cancer.
A graduate of St John’s Medical College at Bangalore University in India, Dr. Kumar obtained his Fellowship in Radiotherapy and Oncology from the Royal College of Radiologists in London, UK in 1982.
Dr. Kumar is also the Chair of the Board of Directors of the Canadian Association of Provincial Cancer Agencies, the Co-Chair of the Canadian Partnership Against Cancer/Canadian Association of Provincial Cancer Agencies Partnership Council, and he serves on the advisory and steering committees of several Partnership initiatives. He has also been a surveyor for Accreditation Canada.
Dr. Kumar has been an active volunteer with the Canadian Cancer Society for over sixteen years and was the President of the New Brunswick division from 2007 to 2009. He has served on the National Board of the Canadian Cancer Society for six years and continues to serve on the New Brunswick divisional board.
Victoria Lee, MD
Dr. Victoria Lee joined the Partnership’s Board of Directors in 2012 and serves on the Governance and Nominating Committee.
Dr. Lee currently serves as Chief Medical Health Officer and Vice-President, Population Health in the Fraser Health Region of British Columbia. As the Chief Medical Health Officer, her primary mandate is to prevent disease, protect health and promote wellness in populations and communities in the Fraser region. She also provides executive leadership and strategic oversight in the areas of population health, prevention of noncommunicable diseases, communicable disease prevention and control, environmental health, licensing of community care facilities and population health surveillance.
Dr. Lee joined Fraser Health in 2010 as a Medical Health Officer and has served as the Executive Medical Director for Population and Public Health since 2012. Prior to joining Fraser Health, she worked in collaboration with national and international organizations including the United Nations Development Programme and the World Bank in the areas of comparative health systems, health policy, health financing and ecohealth. Dr. Lee also worked as a travel physician in rural communities in Chile and Brazil. Her research activities include health equity, community-based primary health system, public health performance and clinical prevention.
Dr. Lee obtained her medical degree from the University of Western Ontario, her royal college fellowship in Community Medicine from the University of Toronto and postgraduate degrees in Public Health, Business Administration from the Johns Hopkins University.
Mary Catherine Lindberg
Mary Catherine Lindberg joined the Partnership’s Board of Directors in 2013.
Ms. Lindberg is the Chair of both the Patented Medicines Prices Review Board and the Board of the Ontario Retirement Homes Regulatory Authority. She also serves as a Director on the Green Shield of Canada Board and on the Hamilton Health Sciences Board.
From 2002 to 2009, Ms. Lindberg was Executive Director of the Council of Academic Hospitals of Ontario. Before that, she was the Assistant Deputy Minister, Health Services with the Ontario Ministry of Health and Long-Term Care, where her responsibilities included the Ontario Health Insurance Plan (OHIP), the Ontario Drug Programs and Private Labs.
Ms. Lindberg has a degree in pharmacy from the University of Saskatchewan and holds a pharmacist license in both Saskatchewan and Ontario.
Shannon MacDonald joined the Partnership’s Board of Directors in 2014.
Ms. MacDonald is a Partner at Deloitte. She leads the firm’s work with the Ontario government, sits on the Toronto Executive and Global Deloitte board, and is the firm’s Chief Inclusion Officer.
Ms. MacDonald’s experience includes 25 years of public accounting and consulting services. She led Deloitte’s professional services presence in Atlantic Canada as Atlantic Managing Partner from 2008 to 2013 and sat on the Executive of Deloitte nationally and on the Canadian board of Deloitte. She has also served as the firm’s national health care leader.
Ms. MacDonald has served as the engagement partner for various Deloitte private company and public sector clients in Ontario and Atlantic Canada. She has conducted due diligence, external audit, risk management, internal audit and governance assignments for various entities. Ms. MacDonald has also designed and delivered governance training and been an active member of the Institute of Corporate Directors and the Ontario Hospital Association’s Governance Centre for Excellence.
Ms. MacDonald sits on the Atlantic Provinces Economic Council and the board of Mount St. Vincent University. She has also sat on the boards of Capital District Health Authority, Women’s College Hospital, Canadian Cancer Society Nova Scotia Division and the Greater Halifax Partnership.
Ms. MacDonald has a Bachelor of Business Administration from the University of Prince Edward Island, a Chartered Accounting designation and a Masters of Health Science from the University of Toronto. She has been recognized for two years as one of the Top 50 CEOs in Atlantic Canada and twice as one of Canada’s 100 Most Powerful Women.
Helen Mallovy Hicks
Helen Mallovy Hicks joined the Partnership’s Board of Directors in 2013 and is Chair of the Finance and Audit Committee.
Ms. Mallovy Hicks is a partner and the GTA Deals leader and former National Leader of PwC’s Valuations, Modelling and Disputes practice. She is a Chartered Business Valuator with over 28 years of independent expert business valuation, litigation support, and related financial advisory experience.
Ms. Mallovy Hicks received her Bachelor of Commerce from the University of Toronto. She subsequently earned her Chartered Accountant (CA), Ontario Institute of Chartered Accountants (1985, Canada) and Fellowship (FCA) designation (2009) and Chartered Business Valuator (CBV), The Canadian Institute of Chartered Business Valuators (1990, Canada) and Fellowship (FCBV) designation (2014).
Ms. Mallovy Hicks is a Member of the Partnership Board at PricewaterhouseCoopers LLP. She is also a past Member of the Board of Directors and past Chair of the Finance & Audit Committee at the Toronto Symphony Orchestra and a former Member of the Board of Trustees of the Toronto Symphony Foundation.
In May 2007, her husband Bob Hicks was diagnosed with lymphoma. After a courageous battle, Bob passed away in February 2012. In overcoming her personal loss, Ms. Mallovy Hicks founded Team Hicksfire in 2012 for the Ride to Conquer Cancer. Together with her team of 50 cyclists, she has to-date raised over $625,000 in support of cancer research for Princess Margaret Hospital, with the goal of reaching $1,000,000 in cumulative donations in 2016. She is also a Vice Chair of the Princess Margaret Cancer Centre Ride to Conquer Cancer.
Crystal Nett joined the Canadian Partnership Against Cancer’s Board of Directors in June 2013.
Ms. Nett is the Associate Vice President Strategy at Saskatchewan Polytechnic. She was previously Chief Financial Officer and Vice President (Finance, Safety & Risk Division) at the Saskatchewan Research Council.
Ms. Nett is a Chartered Professional Accountant (CPA-CA), a Certified Director of the Institute of Corporate Directors of Canada and a Professional Coach.
Ms. Nett has extensive experience in corporate governance and has served on many executive committees and boards of directors.
Ms. Nett is a grateful breast cancer survivor. She hopes to contribute to the fight against the disease that prematurely took her mother and grandmother.
Mary O’Neill joined the Partnership’s Board of Directors in 2015.
Ms. O’Neill is a member of the Strategic Advisory Council of the Canadian Partnership for Tomorrow Project (CPTP), having enrolled as a participant in the Alberta Tomorrow Project, a CPTP regional cohort. She also serves as a public member on the Alberta College of Pharmacists council.
In 2010 Ms. O’Neill retired from her role as Executive Director of the Glenrose Rehabilitation Hospital Foundation. In this role she was involved in successful awareness and fundraising campaigns which resulted in the creation of the Building Trades of Alberta Courage Centre and the Courage in Motion Centre. Both centres house leading-edge rehabilitation technologies.
Ms. O’Neill served two terms as a Member of the Alberta Legislative Assembly representing the constituency of St. Albert from 1997-2004, during which time she was Chairperson of the Government’s Standing Policy Committee on Health and Community Living.
A former high school teacher by profession and a real estate salesperson in business, Ms. O’Neill has played an active leadership role within the volunteer sector. She has served as Trustee and Chairperson of the St. Albert School District, and as a member on the University of Alberta’s Board of Governors and Senate, Edmonton Community Foundation, Alberta Cancer Board, and the Northern Alberta Institute of Technology Board of Governors.
Ms. O’Neill is a graduate of the University of Toronto and the Ontario College of Education.
Arlene Paton joined the Canadian Partnership Against Cancer’s Board of Directors in March 2013.
Ms. Paton became the Assistant Deputy Minister, Population and Public Health at the British Columbia Ministry of Health in September 2011. She is responsible for a team of roughly 130 people working across the health system, government and society on the full range of population and public health programs, services and initiatives. Ms. Paton has worked for the provincial government in Victoria since 1988, where she has also worked in the Ministry of Finance, the Ministry of Advanced Education and the Ministry of Aboriginal Relations and Reconciliation.
Ms. Paton holds a Bachelor of Arts degree from the University of Manitoba and a Master’s degree in Public Administration from Queen’s University.
André Robidoux, MD
Dr. André Robidoux was appointed to the Canadian Partnership Against Cancer’s Board of Directors in 2010. He is a member of the Governance and Nominating Committee.
Dr. Robidoux is Professor of Surgery and Scotia Chair in diagnosis and treatment of breast cancer at the University of Montreal.
Dr. Robidoux received the Distinguished Investigator Lifetime Achievement Award from the NSABP in recognition of his extraordinary commitment to the NSABP and oncology research.
In October 2013, Dr. Robidoux published a book entitled Les raisons d’espérer : ce que la recherché nous apprend sur le cancer du sein.
Gail Turner joined the Partnership’s Board of Directors in 2014.
Ms. Turner is Inuit and a beneficiary of the Labrador Inuit Land Claim. She is retired from the position of Director of Health Services for the Nunatsiavut Government in Northern Labrador.
Ms. Turner holds a Bachelor of Nursing degree from Memorial University of Newfoundland, a Masters of Adult Education from St. Francis Xavier University, and many additional certificates in health and administration through distance programs.
Ms. Turner’s early career was spent in acute care nursing in Ontario and the United Kingdom. She spent 26 years working in Labrador with Inuit, Labrador Métis and First Nations, and since 2004 has worked exclusively with Inuit. Ms. Turner has presented on Inuit health at provincial, regional, national and international meetings and symposiums, including the World Cancer Congress in 2011. She has chaired the National Inuit Committee on Health, the First Nations, Inuit and Métis Advisory Committee of the Canadian Partnership Against Cancer and has been a member of the National Collaborating Centre on Aboriginal Health Advisory Committee and the Institute of Aboriginal People’s Health, CIHR.
Ms. Turner is passionate about the North and the need for First Nations, Inuit and Métis to be heard and truly engaged in the planning of their health care and the promotion of optimal health. Her growing interest is in health equity and the need for innovative and community based solutions for bringing health care services to people.
Ms. Turner was a recipient of the First Nations and Inuit Health Branch Award of Excellence in Nursing in 2007.
Abby Hoffman was appointed Assistant Deputy Minister of the Strategic Policy Branch at Health Canada, October 3, 2011, after acting in the position since January 2011. Prior to this, Ms. Hoffman served as Associate Assistant Deputy Minister of the Strategic Policy Branch. In this capacity, she was responsible for the major files related to the health care system, pharmaceuticals management and regulatory affairs.
Since joining the department in 1993, Ms. Hoffman has held a number of positions at the Associate Assistant Deputy Minister, Director General and senior advisor levels in the areas of women’s health, health system renewal, aging, pharmaceuticals management and therapeutic product regulation. Prior to joining Health Canada, Ms. Hoffman was the Executive Director of the federally-mandated Canadian Panel on Violence against Women. She first joined the federal government in 1981 for a ten year stint as the Director General of Sport Canada.
Ms. Hoffman was made an Officer of the Order of Canada in 1982, and was awarded an Honorary Doctor of Laws degree from York University in 1998. She holds undergraduate and graduate degrees in Political Economy from the University of Toronto. She was an Assistant Professor of Political Studies at the University of Guelph and a senior manager in the Government of Ontario before joining the federal public service.
Jean Latreille, MD
Dr. Jean Latreille joined the Partnership’s Board of Directors in 2012 and serves on the Performance Committee.
Dr. Latreille is the Director of the Direction Québécoise de Cancérologie at the Québec Ministry of Health and Social Services. He is also a professor and the Director of the Medical Oncology Program at the Faculty of Medicine at Sherbrooke University and a hemato-oncologist at Charles LeMoyne Hospital.
Dr. Latreille went to medical school at McGill University, completed his residencies at Montreal General Hospital and Sacré Coeur Hospital, and was a Clinical Fellow at M.D. Anderson Hospital and Tumour Institute in Houston, Texas. He also finished 4 years of post-graduate studies in psychotherapy at the Institut de Formation Humaine Intégrale de Montréal in 1992.
Dr. Latreille has authored or co-authored more than 90 articles and 150 slide presentations or posters at various scientific meetings. He has also been the principal investigator and/or collaborator for over 300 protocols of clinical research at Hotel Dieu de Montreal and Charles LeMoyne Hospital since 1984.
Board of Directors Meeting Highlights
Board Meeting Highlights from 2012 and earlier
Conflict of Interest:
Shelly JamiesonChief Executive Officer
Shelly Jamieson is Chief Executive Officer of the Canadian Partnership Against Cancer (the Partnership), an independent organization funded by Health Canada to accelerate action on cancer control for all Canadians. Ms. Jamieson also serves on the Board of Directors of High Liner Foods, the Finance Committee of the Toronto 2015 Pan Am/Parapan Am Games, the Board of the Gordon Foundation, the Board of Health Quality Ontario, and is Chair of the Ontario Public Service’s Amethyst Awards Selection Committee.
Prior to joining the Partnership in 2012, Ms. Jamieson held Ontario’s highest-ranking civil servant role as Secretary of Cabinet, Head of the Ontario Public Service and Clerk of the Executive Council. She also served as Ontario’s Deputy Minister of Transportation. Roles previously held by Ms. Jamieson include President of Extendicare Canada, a provider of long-term care and home care; volunteer commissioner on the Health Services Restructuring Commission; and Executive Director of the Ontario Long-Term Care Association. Early in her career, Ms. Jamieson ran her own research and consulting firm specializing in geriatric care environments.
For her work, Ms. Jamieson has been inducted into the Hall of Fame of Canada’s Top 100 most powerful women and awarded the Queen’s Diamond Jubilee Medal. Ms. Jamieson has a degree in Urban Studies from the University of Toronto and is also a graduate of the Executive Management Program at the Ivey School of Business, University of Western Ontario.
Heather BryantVice-President, Cancer Control
Heather Bryant, MD, PhD, CCFP, FRCPC, joined the Partnership in January 2008 from the Alberta Cancer Board, where she was Vice-President and Chief Information Officer and Director of the Division of Population Health and Information.
At the Alberta Cancer Board, she was responsible for the cancer registry, screening and prevention programs, as well as an active research unit in cancer epidemiology and prevention. In addition, she led electronic health record implementation.
Dr. Bryant studied medicine at the University of Calgary and took her first residency certification in family medicine. She followed this with a fellowship in community medicine and a PhD in epidemiology, also at the University of Calgary. Dr. Bryant joined the Alberta Cancer Board in 1990. Before that she was a faculty member at the University of Calgary while also a Medical Officer of Health in the Drumheller Health Unit.
Dr. Bryant was elected to the Union for International Cancer Control (UICC) Board of Directors in 2012 and was re-elected in 2014. She co-chaired the scientific program committee for UICC’s World Cancer Congress held in Montreal, Quebec in 2012 and in Melbourne, Australia in 2014.
Dr. Bryant has also been active on many national committees and chaired the National Committee for the Canadian Breast Cancer Screening Initiative (Health Canada), the Joint Advisory Committee on Cancer Control (National Cancer Institute of Canada) and the Population Health Committee (Medical Research Council). She was the inaugural chair of the Institute of Cancer Research’s Advisory Board (Canadian Institutes for Health Research) and of the National Colorectal Cancer Screening Network. Dr. Bryant is also a Clinical Professor in the departments of Community Health Sciences and Oncology at the University of Calgary.
Nicole BebenVice-President, Strategy
Nicole Beben joined the Partnership in September 2014 as Vice-President, Strategy. She brings public and private sector experience leading complex, strategic initiatives and extensive knowledge exchange, stakeholder relations and communications activities.
Most recently, Ms. Beben was Vice-President, Knowledge and Care Exchange Programs at Saint Elizabeth Health Care. In this role she was responsible for advancing cross-cutting strategic initiatives in the majority of provinces and territories to advance social and health outcomes impacting home and community health care. Previously as Executive Director she was responsible for the Care to Know Centre, where she created the first social networking site for home health care stakeholders in Canada.
Earlier roles include leading the strategic community investment portfolio within the national marketing and communications department at TELUS, and creating and implementing health promotion and public awareness campaigns at the Hospital for Sick Children.
Ms. Beben has received a number of awards for her work including the Canadian Public Relations Society National Award of Excellence for Media Relations in 2007 and the International Association of Business Communicators Award of Merit for Media Relations in 2007. Ms. Beben holds an Honours Bachelor of Arts from the University of Guelph and a Master of Arts in Sociology and Anthropology from the University of Victoria and University of Guelph.
David LynchVice President, Finance and Corporate Services
David Lynch joined the Partnership as Vice President, Finance and Corporate Services in 2016. He brings a breadth of executive leadership experience in finance, human resources, change management and operations.
Previously, Mr. Lynch was Associate Deputy Minister, Tax and Benefits Administration with Ontario’s Ministry of Finance. Overseeing an annual budget of almost $500 million, he led the strategy development aimed at tackling contraband tobacco and the ‘underground economy.’ Mr. Lynch has led province-wide service delivery initiatives including the implementation of more collaborative, client-focused finance and corporate service models with the Ministry of Natural Resources and the Ministry of Community Safety and Correctional Services. He is also credited with establishing the organization design and set-up of the Ministry of Aboriginal Affairs in 2006 when he first was appointed to the role of Chief Administrative Officer.
Mr. Lynch also provided leadership across the Ontario Government as Chair of the Chief Administrative Officers Forum, Co-Chair of the Ontario Public Service Human Resources Council and as a member of the OPS Corporate Audit Committee. Outside of the Ontario Government, he has been active with the United Way and with the Conference Board of Canada on the Executive Committee of their Strategic HR Management Council.
Mr. Lynch is a graduate of the University of Waterloo with an honours Bachelor of Environmental Studies in geography and economics, and has completed the Ivey School of Business Executive Program.
Cancer is a complex health challenge that no single organization can address on its own. Together with Canada’s cancer community, the Canadian Partnership Against Cancer is enabling a coordinated approach to reducing the cancer burden on Canadians, with a focus on achieving measurable and concrete outcomes by 2017. The advice, input and expertise from individuals and groups serving in the Partnership’s advisory capacities are critical to ensuring the ongoing relevance and ultimate success of the cancer community’s collective efforts. Bringing a range of perspectives, members of the Partnership’s advisory bodies – the Partnership Cancer Control Council and various Advisory Groups – provide crucial strategic and operational leadership, guiding the Partnership in its work.
PARTNERSHIP CANCER CONTROL COUNCIL
The Partnership Cancer Control Council, chaired by the Vice-President, Cancer Control, meets quarterly, drawing together the experience and knowledge of the organization’s Vice-Presidents, Senior Scientific Leaders and Expert Leads. Senior Scientific Leaders, recognized authorities in their respective areas and affiliated with other organizations active in cancer control, offer vision and oversight, working with staff and partners to leverage expertise, synthesize efforts and identify synergies across initiatives within their portfolios. Expert Leads bring a depth of knowledge in their particular area of expertise, enabling them to spearhead efforts on the Partnership’s key initiatives. As a collective body, this group provides advice and counsel across the organization, supporting implementation of strategic initiatives and driving the work forward.
SENIOR SCIENTIFIC LEADERS
Deborah Dudgeon, MDSenior Scientific Leader, Person-Centred Perspective
Dr. Deborah Dudgeon is a medical oncologist who has focused her clinical practice predominantly in palliative care. In addition to her work at the Canadian Partnership Against Cancer, she is the Head of Palliative Medicine at Queen’s University and Kingston General Hospital. Dr. Dudgeon was the first Head of the Palliative Care Program at Cancer Care Ontario (from 2004 to 2010), where she was instrumental in implementing the Provincial Palliative Care Integration Project.
Dr. Dudgeon is the co-chair of the Advisory Committee on Palliative Medicine for the Conjoint Training Program of the Royal College of Physicians and Surgeons of Canada, and the College of Family Physicians of Canada. She is also a past-President of the Canadian Society of Palliative Care Physicians. She has served as the co-chair of the Symptom Control committee of the National Cancer Institute of Canada Clinical Trials Group and as a member of the Advisory Committee on Research for the National Cancer Institute of Canada.
Dr. Dudgeon received her MD from McMaster University.
Dr. Dudgeon is known internationally for her research into dyspnea (shortness of breath) and is a mentor in the International Palliative Care Leadership Development Program funded by the Open Society Foundation, Center for Global Health National Cancer Institute and Princess of Wales Memorial fund.
Jacques Magnan, PhDSenior Scientific Leader, Canadian Partnership for Tomorrow Project
In his previous role as Chief Executive Officer of Alberta Innovates Health Solutions, a provincial corporation that provides support for health research, Dr. Jacques Magnan was a member of the Canadian Partnership for Tomorrow Project’s Strategic Advisory Council. He continues to provide leadership to the project in his part-time role as Senior Scientific Leader, based out of Alberta.
Dr. Magnan holds a PhD in pharmacology and Bachelor of Science in chemistry/biochemistry from Université de Sherbrooke. He was a post-doctoral fellow in Scotland, Toronto and Montreal, where he also pursued independent research at the Université de Montréal.
With over 22 years of experience in health research management and administration, Dr. Magnan is highly regarded throughout the research community for his ability to build strong relationships with agency leaders and to advance health research at both a provincial and pan-Canadian level. Dr. Magnan has been an active member of the Canadian Cancer Research Alliance since 2005.
David Mowat, MBChBSenior Scientific Leader, Population Health
Dr. David Mowat joined the Partnership as Senior Scientific Leader, Population Health in 2015.
Dr. Mowat is a public health physician with experience at local, provincial and federal levels. Most recently, he was Ontario’s Interim Chief Medical Officer of Health. Previously, he served as Medical Officer of Health for the Region of Peel and Deputy Chief Public Health Officer at the Public Health Agency of Canada. Earlier roles include Consultant for Maternal and Child Health at the Department of Health in Newfoundland, Medical Officer of Health for Kingston and area, and Chief Medical Officer of Health for Ontario. Dr. Mowat is also an adjunct faculty member at McMaster University, Queen’s University and the University of Toronto.
In recognition of his leadership in public health, Dr. Mowat has received the Defries Award of the Canadian Public Health Association and the Distinguished Service Award of the Association of Local Public Health Agencies of Ontario.
Dr. Mowat completed his medical training at the University of Edinburgh and holds a Master of Public Health from the University of California at Berkeley. He is a Fellow of the Royal College of Physicians and Surgeons of Canada (Public Health and Preventative Medicine) and a Fellow (by distinction) of the Faculty of Public Health, Royal Colleges of Medicine (United Kingdom).
Dr. Mowat’s professional interests include chronic disease prevention, the built environment, knowledge translation and workforce development.
Jim Brierley, MDExpert Lead, Staging and Surveillance
Dr. Brierley is a professor in the Department of Radiation Oncology at the University of Toronto and a staff physician with the Department of Radiation Oncology at Princess Margaret Hospital/University Health Network.
Dr. Brierley has a Bachelor of Medicine from London University and is a Fellow of the Royal College of Physicians, the Royal College of Radiologists and the Royal College of Radiation Oncology.
Dr. Brierley’s areas of research are the management of tumours of the thyroid, pituitary and gastrointestinal tract and cancer staging. His current research projects include assessing the role of concurrent chemoradiation in anal and rectal cancer, and determining the value of external beam radiation therapy in thyroid cancer.
Claire de Oliveira, PhDExpert Lead, Cancer Economics
Dr. Claire de Oliveira joined the Canadian Partnership Against Cancer as Expert Lead, Cancer Economics in 2016. In this role, she develops health economics expertise within the Partnership and supports efforts to deepen the capacity to quantify the burden of cancer and assess the economic impact of a coordinated, pan-Canadian approach to cancer control. She also works across cancer control initiatives to quantify efficiencies and support efforts to improve the sustainability of the cancer control system. Dr. de Oliveira is also a member of the Partnership’s Analytic Capacity Building Committee.
Dr. de Oliveira is a health economist at the Centre for Addiction and Mental Health; an assistant professor at the Institute of Health Policy, Management and Evaluation at the University of Toronto; and an adjunct scientist at the Institute for Clinical Evaluative Sciences. Her main areas of cancer-related research include the development of costing methodology, the use of administrative health care data to measure health services utilization and costs, and the assessment of value for money in cancer care.
Dr. de Oliveira holds membership with the Canadian Centre for Applied Research in Cancer Control and is one of the program leads for Health Technology Assessment. In addition, she is a collaborator at the Toronto Health Economics Technology Assessment Collaborative.
Dr. de Oliveira holds Masters of Arts and Doctorate degrees in economics from McMaster University. She also holds a licentiate degree in economics from the University of Oporto in Portugal.
Kathleen Decker, PhDExpert Lead, Cervical Cancer
Dr. Kathleen Decker joined the Partnership in 2010 as Chair, Cervical Cancer Screening Monitoring and Evaluation Group and became Expert Lead, Cervical Cancer in 2015. She is also Chair of the Pan-Canadian Cervical Cancer Screening Network.
Dr. Decker is an epidemiologist at CancerCare Manitoba who has worked with Manitoba screening programs to conduct program evaluation and research since 1995. She is also Assistant Professor, Department of Community Health Sciences, University of Manitoba. Her research interests include cancer screening, cancer epidemiology, chronic disease prevention, and inequities in health care use.
Dr. Decker holds a PhD in Community Health Sciences and Epidemiology from the University of Manitoba.
Elizabeth Eisenhauer, MDExpert Lead, Research
Dr. Eisenhauer is Head of the Department of Oncology, Queen’s University in Kingston and Program Medical Director of the Cancer Centre of Southeastern Ontario at Kingston General Hospital. She served as Chair of the Partnership’s Research Advisory Group during the organization’s first mandate at which time she was also co-chair of the Canadian Cancer Research Alliance, which brings together Canada’s major cancer research funders.
Dr. Eisenhauer received her medical degree from Queen’s University and completed the Royal College of Physicians and Surgeons’ training in both internal medicine and hematology.
For 30 years, Dr. Eisenhauer was Director of the Investigational New Drug Program of the National Cancer Institute of Canada’s Clinical Trials Group at Queen’s University in Kingston, responsible for identifying and bringing to clinical trial novel cancer agents. Dr. Eisenhauer has served on many national and international cancer control bodies, receiving numerous awards recognizing her contribution to the field including the National Cancer Institute of Canada’s O. Harold Warwick Prize and the Presidential Medal Award from the Society of Gynecologic Oncology of Canada. In 2012, she gave the New Drug Development Office (NDDO) Award Lecture at the international conference on targeted anti-cancer therapies in Amsterdam.
Based on her demonstrated leadership, creativity, competence and commitment to the health sciences, in 2013 Dr. Eisenhauer was elected as a fellow of the Canadian Academy of Health Sciences (CAHS).
Christian Finley, MDExpert Lead, Clinical Measures
Dr. Christian Finley is Expert Lead, Clinical Measures at the Canadian Partnership Against Cancer. In this role he provides content-specific advice and expertise on improving the quality of surgical oncology, as well as using Geographic Information Systems spatial mapping techniques to map system performance in cancer control in Canada.
Dr. Finley is a thoracic surgeon with clinical expertise in lung and esophageal cancer, patient education improvements and regionalization efforts. Since 2010, he has practiced at St. Joseph’s Healthcare Hamilton and is currently appointed as an Associate Professor in the Department of Surgery (Division of Thoracic Surgery), McMaster University. He is also the Research Chair for the Canadian Association of Thoracic Surgeons, where he has the opportunity to lead quality improvement projects on a national scale and encourage multi-institutional collaborations.
Dr. Finley has been associated with the Partnership since 2012, collaborating on several fronts including the National Initiative for a Synoptic Operative Report in Lung Cancer, Electronic Synoptic Surgical Quality Initiative and leading the team that produced a discussion paper funded by the Partnership on approaches to high-risk, resource intensive cancer surgical care in Canada released in November 2015. This important study provided objective analyses and discussion about the considerations for the conduct and organization of esophageal, pancreatic, liver, lung and ovarian cancer surgery in Canada.
Dr. Finley trained in General Surgery at University of British Columbia and completed his thoracic surgery training at the University of Toronto. He also has a Masters of Public Health from Harvard University.
Margaret Fitch, PhDExpert Lead, Patient Reported Outcomes
Dr. Margaret Fitch is a Professor in the Bloomberg Faculty of Nursing at the University of Toronto and holds an appointment in the School of Graduate Studies, University of Toronto. Dr. Fitch served as Chair of the Partnership’s Cancer Journey Advisory Group from 2007 to 2012, and currently serves in the capacity of Expert Lead for the Person-Centred Perspective Portfolio. She is also Editor in Chief for the Canadian Oncology Nursing Journal.
Dr. Fitch received her Bachelor of Nursing from Dalhousie University in Halifax and her Master of Science in nursing and doctorate from the University of Toronto.
Dr. Fitch has held a variety of roles from staff nurse to lecturer and author, also pursuing research in the areas of coping and adaptation to illness, focusing on patients’ experiences. She was founding President of the Canadian Association of Nurses in Oncology and President of the International Society of Nurses in Cancer Care and has served on many boards. For her leadership and contribution, she has received a number of awards, including the Award of Excellence in Medical Research and Education from the Canadian Cancer Society in 2011 and a Lifetime Achievement Award from Dalhousie University in 2013.
Jon Kerner, PhDExpert Lead, Knowledge Mobilization and Evaluation
Dr. Jon Kerner joined the Partnership in 2008 and currently serves as Expert Lead, Knowledge Mobilization and Evaluation. He also serves as Chair of the Knowledge Mobilization Steering Committee. Dr. Kerner’s past roles with the Partnership include Senior Scientific Leader, Population Health and Knowledge Management; Senior Scientific Advisor, Knowledge Translation; and Chair of the Primary Prevention Advisory and Action Groups.
Dr. Kerner obtained a Bachelor of Science from McGill University and his PhD in community psychology from New York University. He received post-doctoral training in cancer epidemiology, biostatistics and clinical trials design from the Johns Hopkins University School of Public Health.
Prior to joining the Partnership, Dr. Kerner served as the Deputy Director for Research Dissemination and Diffusion of the Division of Cancer Control and Population Sciences at the U.S. National Cancer Institute. Before that he spent 20 years as a peer-reviewed and funded researcher at two National Cancer Institute-designated comprehensive cancer centres: Memorial Sloan Kettering Cancer Center and Georgetown University’s Lombardi Cancer Center. His community-based cancer control research integrated behavioural science, cancer epidemiology, and health services research and the development of research, practice, and policy partnerships within low income and medically underserved communities. He served on numerous national grant review panels and was the first chair of the National Institutes of Health’s (NIH) Community Prevention and Control Study Section (now the Community-Led Health Promotion Study Section).
Verna Mai, MDExpert Lead, Screening
Dr. Mai is an assistant professor at the Dalla Lana School of Public Health at the University of Toronto. She served as Chair of the Partnership’s Screening Advisory Group from 2007 to 2012.
Dr. Mai received her medical degree from the University of Alberta and completed her specialty training in community medicine at the University of Toronto.
Dr. Mai spent 10 years with Cancer Care Ontario, holding a variety of leadership positions, including that of Director of Screening Programs. Previously, she served as the Medical Officer of Health at the Elgin-St. Thomas Health Unit and as the Associate Medical Officer of Health and Director of Education and Research at the Middlesex-London Health Unit.
Anthony Miller, MDExpert Lead, Cancer Risk Management
Dr. Anthony Miller is Expert Lead for Cancer Risk Management with the Partnership, which includes chairing the Cancer Risk Management Steering Committee.
Dr. Miller is Professor Emeritus at the Dalla Lana School of Public Health at the University of Toronto. He is Director of the Canadian National Breast Screening Study and acts as an independent research consultant.
Dr. Miller received his Bachelor of Medicine from the University of Cambridge after training at St. Bartholomew’s Hospital Medical School in London, U.K.
Dr. Miller’s career has spanned the world, from work in epidemiology with the UK Medical Research Council, to serving as a special expert in cancer prevention with the United States National Cancer Institute and as the Head, Division of Cancer Epidemiology with the German Cancer Research Centre in Heidelberg. He has also been a consultant to the World Health Organization. In Canada, he has been the Director of the Epidemiology Unit of the National Cancer Institute of Canada and Associate Director of Research at the University of Toronto’s Dalla Lana School of Public Health, among other positions.
Geoff Porter, MDExpert Lead, Clinical Care
Dr. Geoff Porter is Expert Lead, Clinical Care. He previously served as the Partnership’s inaugural Senior Scientific Leader, Diagnosis and Clinical Care.
Serving in his Partnership role on a part-time basis, Dr. Porter is a Professor of Surgery and the Ramia Chair in Surgical Oncology at Dalhousie University. He also serves as Director of the Cancer Outcomes Research Unit in Halifax, where he has worked to generate standard research metrics in the forms of publications and grants, as well as significant knowledge translation and exchange activities, resulting in tangible clinical change. In the past, he has served as the Head of the Cancer Care Program in Halifax, as well as the Chair of Surgical Quality Control for the Radiation Therapy Oncology Group (RTOG).
Dr. Porter studied medicine at Queen’s University in Kingston, Ontario and also holds a Master of Science in medical sciences, specializing in epidemiology, from the University of Alberta. He trained in Surgical Oncology at the MD Anderson Cancer Center in Houston, Texas.
Over the past several years, Dr. Porter has participated in several Partnership initiatives, working groups, steering committees and reports, notably as Clinical Lead for breast cancer surgery in the Synoptic Reporting Tools Project. In addition, he acted as Chair of the Electronic Synoptic Surgery Quality Initiative which has led to the doubling of surgeons using synoptic reporting tools with a focus on using the results to further cancer control. He also led the Partnership’s submission for the Choosing Wisely Canada oncology list of recommendations to identify low-value or potentially harmful practices, contributing to landmark recommendations for the cancer control community.
John Srigley, MDExpert Lead, Pathology
Dr. Srigley is the Chief and Medical Director of the Program of Laboratory Medicine and Genetics at Trillium Health Partners, and a Professor in the Department of Pathology and Molecular Medicine at McMaster University. He also represents Canada on the American Joint Committee on Cancer. In addition to his role as Expert Lead, Pathology, Dr. Srigley is Chair of the National Pathology Standards Committee at the Canadian Partnership Against Cancer.
Dr. Srigley is a graduate of the Faculty of Medicine, University of Toronto, where he also received pathological training, which he continued at MD Anderson Cancer Centre in Houston.
Previously, Dr. Srigley was the inaugural Head of Pathology and Laboratory Medicine Program at Cancer Care Ontario. Dr. Srigley is a Past President of both the International Society of Urological Pathologists and the Ontario Association of Pathologists. Dr. Srigley was a key leader in completing the Partnership’s National Staging Initiative and securing formal endorsement of the College of American Pathology cancer checklists as pan-Canadian content standards for cancer pathology reporting. An international consultant and educator in the fields of oncologic and urologic pathology, Dr. Srigley has contributed extensively to the literature and strongly advocated for population-level standardized synoptic pathology reporting and the role of the pathologist in cancer control.
Terry Sullivan, PhDExpert Lead, Quality Initiatives
Dr. Terry Sullivan is Expert Lead for Quality Initiatives with the Partnership, where he has also served as Chair, Quality Initiatives and System Performance since 2011.
A behavioural scientist, Dr. Sullivan is a professor and senior fellow at the University of Toronto’s Institute of Health Policy, Management & Evaluation and the Dalla Lana School of Public Health. He is adjunct professor of Oncology at McGill University and Associate Scientist at the Li Ka Shing Knowledge Institute at St. Michael’s Hospital. Among other commitments, Dr. Sullivan chairs the board for the Canadian Agency for Drugs and Technologies in Health and for Public Health Ontario. He is a trustee of the Hospital for Sick Children.
Dr. Sullivan has served in a number of governance and advisory roles in health services and health policy. He was President and CEO of Cancer Care Ontario and founding President of the Institute for Work & Health. Dr. Sullivan has held senior positions in Ontario ministries of Health and Intergovernmental Affairs, and served two Ontario First Ministers through the Premier’s Council on Health Strategy among others.
Advisory Groups are aligned with the following cancer control priority areas: Early Diagnosis and Clinical Care, Person-Centred Perspective, Population Health and Research. Chaired by recognized experts in their respective fields, these groups encompass members representing key partner organizations, regions and perspectives and coming from a wide variety of backgrounds: health practitioners, administrators, epidemiologists, researchers, patients, family members and the public. Together, they support the work of each priority area, ensuring the Partnership contributes to ongoing initiatives, supports new advances and identifies emerging issues. Playing a similar role for the First Nations, Inuit and Métis priority area is the ‘National Aboriginal Organizations Caucus with Canadian Partnership Against Cancer,’ which has representation from the Assembly of First Nations, Métis National Council and Inuit Tapiriit Kanatami.